FUL

H.B. Fuller is a globally diversified industrial adhesives specialist showing classic late-cycle stabilization: FY2025 revenue slipped 2.7% to $3.47B, yet net income rose 16.7% to $152M and diluted EPS jumped 19.6% to $2.75. Gross profit expanded 1.8% on a smaller top line, lifting gross margin to 31.1% — evidence that the 2023 restructuring Plans (now complete at $79.2M of the $80-85M budget) and pricing actions are flowing through. Operating cash flow of $263M comfortably funded $142M of capex (heavily skewed toward the long-running Project ONE ERP rollout, ~$165M of the $265M to-date is capex), $60.7M of buybacks (up 53.5%) and $50.3M of dividends, signaling management confidence in cash generation.

The balance sheet is the principal restraint. Long-term debt of $2.02B against $2.00B of equity (liabilities/equity 1.59x) and only $107M of cash (down 36.7% YoY) leaves limited dry powder, and the 10-K flags that a 1-point rate move on variable debt would swing net income by $6.6M ($0.12/share) — meaningful against $2.75 EPS. Layer on the disclosed sensitivities — a 1% FX-driven COGS change worth $9.1M ($0.17/share) and a 10% USD move worth $18M ($0.32/share), with 56% of revenue ex-US and exposure to Turkish lira, Egyptian pound and Brazilian real — and reported earnings carry real translation volatility. Raw-material concentration in resins, polymers and petroleum derivatives (ethylene/propylene/waxes) adds another margin variable management explicitly calls out.